BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29604207)

  • 1. Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5.
    Xie X; Xu X; Sun C; Yu Z
    Biol Chem; 2018 May; 399(6):611-619. PubMed ID: 29604207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
    Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
    Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
    Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2.
    Tian JH; Liu WD; Zhang ZY; Tang LH; Li D; Tian ZJ; Lin SW; Li YJ
    J Viral Hepat; 2019 Apr; 26(4):496-505. PubMed ID: 30521133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
    Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
    Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV‑related hepatocellular carcinoma by targeting estrogen receptor-α.
    Chen JJ; Tang YS; Huang SF; Ai JG; Wang HX; Zhang LP
    Oncol Rep; 2015 Feb; 33(2):792-8. PubMed ID: 25483016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
    Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
    Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
    Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F; You X; Chi X; Wang T; Ye L; Niu J; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):128-34. PubMed ID: 24434140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.
    Zhang Q; Song G; Yao L; Liu Y; Liu M; Li S; Tang H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):14. PubMed ID: 29378599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.